Therapy Areas: Autoimmune
Moderna Receives Funding Award from CEPI to Accelerate Development of Messenger RNA Vaccine Against Novel Coronavirus
27 January 2020 - - US-based clinical stage biotechnology company Moderna, Inc., (NASDAQ: MRNA) has forged a new collaboration to develop an mRNA vaccine against the novel coronavirus (2019-nCoV), the...
Foghorn Therapeutics Names Biller to Board of Directors
14 January 2020 - - US-based Foghorn Therapeutics Inc., a company advancing an entirely new class of medicines targeting diseases with genetically determined dependencies in the chromatin regulat...
Jasper Therapeutics Expands Series A Financing, Bringing Total Corporate Fundraising to More than USD 50m
14 January 2020 - - US-based biotechnology company Jasper Therapeutics, Inc has expanded its series A financing with an additional investment of USD 14.1m led by Roche Venture Fund and with participat...
SAB Biotherapeutics signs multiple collaboration and option agreements with CSL Behring
9 January 2020 - SAB Biotherapeutics, a clinical-stage biopharmaceutical development company advancing a new class of immunotherapies, has signed multiple collaboration and option agreements with glob...
SAB Biotherapeutics signs new autoimmune research collaboration with CSL Behring
8 January 2020 - Biopharmaceutical company SAB Biotherapeutics (SAB) said on Tuesday that it has entered into a multiple research collaboration and option agreement with CSL Behring to treat challengi...
Golan Bitton Univo Pharmaceutical CEO Elected to the Can-Fite Board
30 December 2019 - - Golan Bitton, CEO of Univo Pharmaceuticals (TASE: UNVO), was elected as a board member to Israel-based biotechnology company Can-Fite BioPharma Ltd. (NYSE American: CANF...